Download - ISPOR 15th Annual European Congress Disclosure Information for Research Presentations

ISPOR 15TH ANNUAL EUROPEAN CONGRESS DISCLOSURE INFORMATION FOR RESEARCH PRESENTATIONS

The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose financial support for their research.The following financial support was declared:

ReferenceCode Financial Support


CA1 French National Cancer Institute (INCa), Boulogne-Billancourt, FranceCA2 Costello Medical Consulting Ltd., Cambridge, UKCA3 NoneCA4 Bristol Myers-Squibb, Uxbridge, UKCL1 NoneCL2 Millennium, Boston, MA, USACL3 NoneCL4 PFIZER Italia S.R.L., Roma, ItalyCV1 British Heart Foundation, London, UKCV2 The Center for Translational Molecular Medicine, Eindhoven, NetherlandsCV3 Sorin Cardio Biomedica, Saluggia, ItalyCV4 Italian Ministry of Health, Rome, Italy; Regione Lombardia, Milan, ItalyDB1 NoneDB2 NovoNordisk, Warsaw, PolandDB3 Novartis Farmaceutica, Barcelona, SpainDB4 Novo Nordisk, Copenhagen, DenmarkDU1 NoneDU2 NoneDU3 H. Lundbeck A/S, Copenhagen, DenmarkDU4 Serbian Ministry of science, Belgrade, Serbia and MontenegroMA1 NoneMA2 UCB Pharma, Slough, UKMA3 JANSSEN-CILAG, SAO PAULO, BrazilMA4 Teva Pharmaceuticals, Horsham, PA, USAMO1 Lundbeck, Issy les Moulineaux, FranceMO2 GlaxoSmithKline, Zeist, NetherlandsMO3 COMET Center ONCOTYROL, Innsbruck, Austria; Tiroler Zukunftsstiftung/

Standortagentur Tirol (SAT), Innsbruck, AustriaMO4 Pfizer UK, Tadworth, UKNI1 NoneNI2 Costello Medical Consulting Ltd, Cambridge, UKNI3 NoneNI4 NonePA1 Double Helix Consulting, London, UKPA2 Ministry of Health, rome, ItalyPA3 CEESTAHC, Krakow, PolandPA4 Baxter Healthcare Corporation, Braine l’Alleud, BelgiumPCN1 Eisai, Inc, Woodcliff Lake, NJ, USAPCN2 Janssen-Cilag, Neuss, ME, GermanyPCN3 Amgen Inc., Thousand Oaks, CA, USAPCN4 FFG-Österreichische Forschungsförderungsgesellschaft, Wien, AustriaPCN5 Sanofi Aventis Deutschland GmbH, Frankfurt, GermanyPCN6 Netherlands Organisation for Health Research and Development (ZonMw),

Den Haag, Netherlands; Roche Nederland B.V., Woerden, Netherlands; PfizerB.V., Capelle aan den IJssel, Netherlands

PCN7 Eli Lilly and Company, Indianapolis, IN, USAPCN8 Pfizer Global Pharmaceuticals, New York, NY, USAPCN9 Amgen Inc, Thousand Oaks, CA, USAPCN10 Eisai, Inc, Woodcliff Lake, NJ, USAPCN11 Celgene, Summit, NJ, USAPCN13 GlaxoSmithKline, Zeist, NetherlandsPCN14 NonePCN15 Agency for Health Technology Assessment In Poland (AHTAPol), Warsaw,

PolandPCN16 Pfizer Poland, Warsaw, PolandPCN17 Roche Farmaceutica QUımica, Lda., Amadora, PortugalPCN19 NonePCN20 National Evidence-based Healthcare Collaborating Agency, Seoul, South

KoreaPCN21 Bristol Myers Squibb, Sao Paulo, BrazilPCN22 NonePCN23 NonePCN24 Pfizer, New York, NY, USAPCN25 Roche, Moscow, RussiaPCN26 NonePCN27 Janssen-Cilag GmbH, Neuss, GermanyPCN28 NonePCN29 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN30 NonePCN31 NonePCN32 NonePCN33 NonePCN34 Lundbeck Canada, Montreal, QC, CanadaPCN35 Sanofi, Chilly Mazarin, France

PCN36 Pliva Croatia Ltd., Zagreb, CroatiaPCN37 NonePCN38 United BioSource Corporation, Bethesda, MD, USAPCN39 Roche Products Limited, Welwyn Garden City, UKPCN40 NonePCN41 Nestle Health Science, Vevey, SwitzerlandPCN42 French National Cancer Institute (INCa), Boulogne-Billancourt, FrancePCN43 NonePCN44 Roche Austria, Vienna, AustriaPCN45 William Harvey Research Institute, London, UKPCN46 Janssen, Madrid, SpainPCN47 Deutsche Krebshilfe e. V., Bonn, GermanyPCN48 Sanofi Pasteur MSD, Maidenhead, UKPCN49 Brystol-Myers Squibb, Moscow, RussiaPCN50 Roche, Basel, SwitzerlandPCN51 Genentech, South San Francisco, CA, USAPCN52 Sanofi Pasteur MSD, Maidenhead, UKPCN53 NonePCN54 NonePCN55 NonePCN56 Sanofi Pasteur MSD, Maidenhead, UKPCN57 Janssen, the pharmaceutical division of Johnson & Johnson LLC, Moscow,

Russia; Ferring Pharmaceuticals, LLC, Moscow, RussiaPCN58 The research is supported by the German Federal Ministry of Education and

Research (BMBF), project grant No. 01EX1013B as part of the Centre ofExcellence for Medical Technology, Bonn, Germany

PCN59 Novartis Pharma AG, Basel, SwitzerlandPCN60 NonePCN61 Bristol Myers Squibb, Sao Paulo, BrazilPCN62 Caris Life Sciences, Irving, TX, USAPCN63 Bristol-Myers Squibb, Madrid, SpainPCN64 Novartis Biociencias SA, Sao Paulo, BrazilPCN65 Expanded Program on Immunization, Colombian Ministry of Health and Social

Protection, Bogota, ColombiaPCN66 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN67 NonePCN68 ZONMW, Den Haag, Netherlands; Roche B.V., Woerden, NetherlandsPCN69 NonePCN70 Ferring International Center SA , Saint-Prex, SwitzerlandPCN71 NonePCN72 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPCN73 Pfizer S.A. de C.V., Mexico City, MexicoPCN74 Baxter Healthcare SA, Zurich, SwitzerlandPCN75 Pfizer AB, Stockholm, SwedenPCN76 Roche Farma S.A., Madrid, SpainPCN77 NonePCN78 Sanofi Espana, Barcelona, SpainPCN79 �elgene, Moscow, RussiaPCN80 Bristol Mysers-Squibb, Uxbridge, UKPCN81 GlaxoSmithKline, Uxbridge, UKPCN82 Roche Farma S.A., Madrid, SpainPCN83 NonePCN84 Janssen Cilag Pharmaceutical SACI, Athens, GreecePCN85 NonePCN86 JANSSEN-CILAG, SAO PAULO, BrazilPCN87 Roche, Mexico City, MexicoPCN88 NonePCN89 Abbott Laboratories, Abbott Park, IL, USAPCN90 Mundipharma, Hoevelaken, NetherlandsPCN91 Roche Farmaceutica Quimica, Amadora, PortugalPCN92 Novartis, Moscow, RussiaPCN93 Pfizer Poland, Warsaw, PolandPCN94 IMS Health , Alexandria , VA, USAPCN95 Roche Products Pty Ltd., Dee Why, AustraliaPCN96 Roche Hong Kong, Hong Kong, Hong KongPCN97 NonePCN98 Novartis Pharma AG, Basel, SwitzerlandPCN99 Amgen GmbH, Zug, SwitzerlandPCN100 Janssen-Cilag Ltd., Buckinghamshire, UKPCN101 NonePCN102 Bayer Healthcare Pharmaceuticals, Inc., Wayne, NJ, USAPCN103 NonePCN104 Roche Brazil, Sao Paulo, BrazilPCN105 Genentech Inc, San Francisco, CA, USA

A576 V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 5 7 6 - A 5 8 6

Copyright © 2012, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

PCN106 NonePCN107 Pfizer GmbH, Berlin, GermanyPCN108 Eisai, Woodcliff Lake, NJ, USAPCN109 FFG-Österreichische Forschungsförderungsgesellschaft, Wien, AustriaPCN110 Canadian Cancer Society Research Institute, Toronto, ON, Canada; National

Institute of Health, Bethesda, MD, USAPCN111 Ontario Institute for Cancer Research, Toronto, ON, CanadaPCN112 NonePCN113 Genentech, South San Francisco, CA, USAPCN114 Millennium Pharmaceuticals, Inc, Cambridge, MA, USAPCN115 NonePCN116 Janssen Pharmaceutica N.V., Beerse, BelgiumPCN117 Fresenius Biotech GmbH, Munchen, GermanyPCN118 Amgen (Europe) GmbH, Zug, SwitzerlandPCN119 NonePCN120 Janssen Pharmaceutica, Beerse, BelgiumPCN121 Janssen Pharmaceutica N.V., Beerse, BelgiumPCN122 Amgen, Thousand Oaks, CA, USAPCN123 Genentech, Inc., South San Francisco, CA, USAPCN124 National Science Centre, Cracov, PolandPCN125 National Science Centre, Cracov, PolandPCN126 ZONMW, Den Haag, Netherlands; Janssen, Tilburg, NetherlandsPCN127 Health Care Insurance Board, Diemen, NetherlandsPCN128 NonePCN129 NonePCN130 NonePCN131 NonePCN132 Astrazeneca, Luton, UKPCN133 NonePCN134 NonePCN135 IMS Health, PARIS, FrancePCN136 Novartis Pharmaceuticals Canada, Dorval, QC, CanadaPCN137 IMS Health, London, UKPCN138 Sanofi, Bridgewater, NJ, USAPCN139 Ipsen Pharma SAS, Boulogne-Billancourt, FrancePCN140 Janssen Pharmaceutica, Beerse, BelgiumPCN141 Amgen BV, Breda, NetherlandsPCN142 NonePCN143 Sanofi, Guildford, UKPCN144 Costello Medical Consulting Ltd, Cambridge, UKPCN145 NonePCN146 NonePCN147 NonePCN148 Eli Lilly and Company, Indianapolis, IN, USAPCN149 Astellas Pharma Global Development, Leiderdorp, NetherlandsPCN150 NonePCN151 NonePCN152 German Association of Research-based Pharmaceutical Companies (vfa),

Berlin, GermanyPCN153 Oncotyrol, Innsbruck, AustriaPCN154 NonePCN155 NonePCN156 NonePCN157 NonePCN158 Cancer Care Ontario, Toronto, ON, Canada; Ontario Ministry of Health &

Long Term Care, Toronto, ON, Canada; Ontario Institute for CancerResearch, Toronto, ON, Canada

PCN159 Bristol Myers Squibb, Sao Paulo, BrazilPCV1 NonePCV2 NonePCV3 Merck, Whitehouse Station, NJ, USAPCV4 St.Luke’s Life Science Institute, Tokyo, JapanPCV5 NonePCV6 NonePCV7 National Institute for Health Research, Southampton, UKPCV8 Eli Lilly and Company, Indianapolis, IN, USA; Daiichi Sankyo Company,

Limited, Parsippany, NJ, USAPCV9 NonePCV10 NonePCV11 The Health Council of The Netherlands, The Hague, NetherlandsPCV12 Novartis Pharma AG, Basel, SwitzerlandPCV13 LA-SER Europe Ltd., London, UKPCV14 Daiichi Sankyo, Parsippany, NJ, USAPCV15 Bristol-Myers Squibb, Rueil-Malmaison, FrancePCV16 NonePCV17 Bristol-Myers Squibb, Rueil-Malmaison, FrancePCV18 NonePCV19 NonePCV20 NonePCV21 NonePCV22 None

PCV23 NonePCV24 BERLIN-CHEMIE, Moscow, RussiaPCV25 Eli Lilly and Company, Indianapolis, IN, USA; Daiichi Sankyo Company,

Limited , Parsippany, NJ, USAPCV26 AstraZeneca Pharmaceuticals, Moscow, RussiaPCV27 NonePCV28 Bristol-Myers Squibb, Rueil-Malmaison, France; Pfizer, Paris, FrancePCV29 Pfizer, Alcobendas, SpainPCV30 Abbott Vascular, Diegem, BelgiumPCV31 Ministry of Science and Environmental Protection of the Republic of Serbia ,

Belgrade, Serbia and MontenegroPCV32 NonePCV33 NonePCV34 Eli Lillly Company Turkey, Istanbul, TurkeyPCV35 Amgen, Munchen, GermanyPCV36 Actavis Deutschland GmbH & Co. KG , Munchen, GermanyPCV37 Bristol Myers Squibb, Sao Paulo, BrazilPCV38 The Medicines Company, Parsippany, NJ, USAPCV39 Pfizer, Mexico, Mexico; Bristol-Myers Squibb, Mexico, MexicoPCV40 NonePCV41 Bayer HealthCare, Moscow, RussiaPCV42 Bayer HealthCare, Moscow, RussiaPCV43 NonePCV44 Novartis, Hellas, GreecePCV45 AstraZeneca Turkey, Istanbul, TurkeyPCV46 Bayer HealthCare Pharmaceuticals, Moscow, RussiaPCV47 The Health Council of The Netherlands, The Hague, NetherlandsPCV48 Janssen Pharmaceuticals, Inc., Raritan, NJ, USAPCV49 Bayer, Athens, GreecePCV50 AstraZeneca, Wanchai, Hong KongPCV51 Bayer HealthCare AG, Wuppertal, GermanyPCV52 Merck, Sharp & Dohme, Paco de Arcos, PortugalPCV53 Novartis, Hellas, Greece; Novartis, Hellas, GreecePCV54 Bayer, Athens, GreecePCV55 SERVIER ILAÉ A.S¸., Istanbul, TurkeyPCV56 MSD, Sao Paolo City, BrazilPCV57 NonePCV58 NonePCV59 Medical Research Council, London, UK; National Institute for Health

Research, London, UKPCV60 NonePCV61 Berlin-Chemie, Moscow, RussiaPCV62 ZAO �Corporation OLIFEN, Moscow, RussiaPCV64 AstraZeneca, Brussels, BelgiumPCV65 Abbott Laboratories, Allschwil, SwitzerlandPCV66 Nycomed: A Takeda Company, Mexico, Mexico City, MexicoPCV67 Engineering and Physical Sciences Research Council (EPSRC), Swindon, UKPCV68 GlaxoSmithKline, Madrid, SpainPCV69 FERRER-inCode, Barcelona, SpainPCV70 Pfizer Nederland, Capelle aan den Ijssel, NetherlandsPCV71 NonePCV72 Bayer Healthcare, Barcelona, SpainPCV73 Bayer, Bratislava, Slovak RepublicPCV74 FERRER-inCode, Barcelona, SpainPCV75 Bayer Pharma AG, Berlin, GermanyPCV76 AstraZeneca SpA, Milano, ItalyPCV77 Nestle Health Science, Lutry, SwitzerlandPCV79 Boehringer Ingelheim Pty Limited, Sydney, AustraliaPCV80 Novartis, Seoul, South KoreaPCV81 Care For Your Heart, Hong Kong, Hong KongPCV82 Novartis Hellas, Metamorfosis, GreecePCV83 NonePCV84 NonePCV85 NonePCV86 Kantar Health, New York, NY, USAPCV87 NonePCV88 Bayer HealthCare Pharmaceuticals, Wuppertal, GermanyPCV89 Netherlands Organisation for Health Research and Development (ZonMw),

The Hague, NetherlandsPCV90 Novartis Pharmaceuticals, Basel, SwitzerlandPCV91 Sanofi Aventis S.A., Barcelona, SpainPCV92 NonePCV93 NonePCV94 Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, GermanyPCV95 Novartis Pharma AG, Basel, SwitzerlandPCV96 Novartis Pharma AG, Basel, SwitzerlandPCV97 Bayer Yakuhin, Ltd., Tokyo, JapanPCV98 Novartis Farmaceutica, Barcelona, SpainPCV99 Health Institute Carlos III, Madrid, SpainPCV100 Kantar Health, Princeton, NJ, USAPCV101 Bayer Yakuhin, Ltd., Tokyo, Japan



A577V A L U E I N H E A L T H 1 5 ( 2 0 1 2 ) A 5 7 6 - A 5 8 6

PCV102 Bayer Yakuhin Ltd., Tokyo, JapanPCV103 Pfizer, Madrid, SpainPCV104 NonePCV105 MSD, Hoddesdon, UKPCV106 Novartis Pharma, Cairo, EgyptPCV107 TEVA, Wilrijk, BelgiumPCV108 Ministry of Science and Higher Education, Warsaw, Poland; Jagiellonian

University, Krakow, PolandPCV109 Bayer HealthCare Pharmaceuticals, Berlin, GermanyPCV110 Daiichi Sankyo, Parsippany, NJ, USAPCV111 Sanofi, Chilly-Mazarin, FrancePCV112 NonePCV113 NonePCV114 NonePCV115 Kantar Health GmbH, Munchen, GermanyPCV116 RQRUM, Montreal, QC, Canada; Pfizer, Montreal, QC, Canada; sanofi-aventis,

laval, QC, CanadaPCV117 Italian Medicines Agency, Rome, ItalyPCV118 NonePCV119 NonePCV120 NonePCV121 Novartis Farmaceutica, S.A., Barcelona, SpainPCV122 NonePCV123 Bristol Myers Squibb, Sao Paulo, BrazilPDB1 sanofi-aventis U.S., Bridgewater, NJ, USAPDB2 Bristol Myers Squibb, Wallingford, CT, USAPDB3 sanofi-aventis U.S., Bridgewater, NJ, USAPDB4 Takeda Pharmaceuticals International, Inc., Deerfield, IL, USAPDB5 sanofi-aventis U.S., Bridgewater, NJ, USAPDB6 sanofi-aventis U.S., Bridgewater, NJ, USAPDB7 Eli Lilly & Company, Indianapolis, IN, USAPDB8 Bristol-Myers Squibb, Princeton, NJ, USAPDB9 NonePDB10 Novartis Pharma AG, Basel, SwitzerlandPDB11 NonePDB12 NonePDB13 Novartis, Rueil Malmaison, FrancePDB14 NonePDB15 Boehringer Ingelheim GmbH, Ingelheim, GermanyPDB16 NonePDB17 European Commission, Brussels, BelgiumPDB18 AstraZeneca pharmaceuticals LP, Wilmington, DE, USA; Bristol-Myers Squibb

, Pennington, NJ, USAPDB19 Novo Nordisk Ltd, Crawley, UKPDB20 NonePDB21 Novartis, East Hanover, NJ, USAPDB22 Boehringer-ingelheim, Paris, FrancePDB23 NonePDB24 Pfizer S.L.U., Madrid, SpainPDB25 NonePDB26 NonePDB27 The Society of Endocrinology and Metabolism of Turkey, Istanbul, TurkeyPDB28 The Society of Endocrinology and Metabolism of Turkey, Istanbul, TurkeyPDB29 MSD Italia Srl, Rome, ItalyPDB30 NonePDB31 The Society of Endocrinology and Metabolism of Turkey, Istanbul, TurkeyPDB32 National Science Centre, Cracov, PolandPDB33 Merck SL, Madrid, SpainPDB34 Ontario Ministry of Health, Toronto, ON, CanadaPDB35 Novo Nordisk, Zurich, SwitzerlandPDB36 Novo Nordisk, Zurich, SwitzerlandPDB37 Eli Lilly and Company, Indianapolis, IN, USAPDB38 NovoNordisk, Warsaw, PolandPDB39 Novo Nordisk, Zurich, SwitzerlandPDB40 Janssen Global Services, LLC, Ratitan, NJ, USAPDB41 Novo Nordisk, Zurich, SwitzerlandPDB42 Novo Nordisk, Zurich, SwitzerlandPDB43 Novartis, Hellas, GreecePDB44 Novo Nordisk, Zurich, SwitzerlandPDB45 Novartis, Basel, SwitzerlandPDB46 Merck, Sharp & Dohme, Paco de Arcos, PortugalPDB47 Novo Nordisk, Copenhagen, SwedenPDB48 Novartis Canada, Montreal, QC, CanadaPDB49 Novartis Canada, Dorval, QC, CanadaPDB50 Novartis Canada, Dorval, QC, CanadaPDB51 Novartis Pharmaceuticals Canada, Dorval, QC, CanadaPDB52 Novo Nordisk, Princeton, NJ, USAPDB53 Novartis, Hellas, Greece; Novartis, Hellas, GreecePDB54 IMS Health, London, UKPDB55 Pfizer, Inc, New York, NY, USAPDB56 Takeda Pharmaceuticals, Deerfield, IL, USA

PDB57 Boehringer Ingelheim, Ingelheim am Rhein, GermanyPDB58 NonePDB59 Novartis Pharma AG, Basel, SwitzerlandPDB60 Novartis Farmacautica, Barcelona, SpainPDB61 NonePDB62 NonePDB63 Novartis, East Hanover, NJ, USAPDB64 Bristol-Myers Squibb, Rueil Malmaison, France; AstraZeneca, Zaventem,

BelgiumPDB65 The Society of Endocrinology and Metabolism of Turkey, Istanbul, TurkeyPDB66 AstraZeneca, Molndal, SwedenPDB68 Eli Lilly & Company, Indianapolis, IN, USAPDB69 NonePDB70 Ipsen Pharma SAS, Boulogne-Billancourt, FrancePDB71 NonePDB72 Almirall, Barcelona, SpainPDB73 NonePDB74 NonePDB75 Novo Nordisk Inc., Princeton, NJ, USAPDB76 IQWiG, cololgne, GermanyPDB77 Ontario Ministry of Health, Toronto, ON, CanadaPDB78 Eli Lilly and Company, Indianapolis, IN, USAPDB79 Eli Lilly and Company, Indianapolis, IN, USAPGI1 NonePGI2 Merck Sharp & Dohme - Portugal, Lisbon, PortugalPGI3 Janssen-Cilag Polska, Warsaw, PolandPGI4 NonePGI5 Pfizer Ltd., Mumbai, IndiaPGI6 Ferrer Internacional, Barcelona, SpainPGI7 Shire Development LLC, Wayne, PA, USAPGI8 NonePGI9 NonePGI12 Abbott Laboratories, Zagreb, CroatiaPGI13 Shire, Eysins, SwitzerlandPGI14 NonePGI15 Ferrer Internacional, Barcelona, SpainPGI16 MSD, Sao Paulo, BrazilPGI17 Health Labour Sciences Research Grant, Tokyo, JapanPGI18 Merck Sharp & Dohme Ltd., Hoddesdon, UKPGI19 Janssen-Cilag GmbH, Neuss, GermanyPGI20 Abbott Laboratories, Abbott Park, IL, USAPGI21 MSD, Sao Paulo, BrazilPGI22 Nycomed: A Takeda Company, Mexico, Mexico City, MexicoPGI23 NonePGI24 Shanghai Roche, Shanghai, ChinaPGI25 Janssen, Bratislava, Slovak RepublicPGI26 Almirall, Barcelona, SpainPGI27 Forest Laboratories, Jersey City, NJ, USAPGI28 Janssen, Issy-les-Moulineaux, FrancePGI29 Janssen-Cilag Polska , Warsaw, PolandPGI30 Forest Research Institute, Jersey City, NJ, USA; Ironwood Pharmaceuticals,

Cambridge, MA, USAPGI31 Ironwood Pharmaceuticals, Cambridge, MA, USA; Forest Research Institute,

Jersey City, NJ, USAPGI32 NonePGI33 Danone, Palaiseau, FrancePGI34 NonePGI35 Baxter, Milano, ItalyPGI36 NonePGI37 Abbott, Rungis, FrancePGI38 NonePGI39 MSD Bulgaria, Sofia, BulgariaPGI40 Shire , Wayne, PA, USAPHP1 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPHP2 NonePHP3 The Netherlands Organisation for Health Research and Development, Den

Haag, NetherlandsPHP4 NonePHP5 NonePHP6 NonePHP7 The European Health Technology Institute, Brussels, BelgiumPHP8 IHS, London, UKPHP9 NonePHP10 Richter Gedeon Nyrt., Budapest, HungaryPHP11 NonePHP12 University of Geneva hospitals, Geneva, SwitzerlandPHP13 Richter Gedeon Nyrt., Budapest, HungaryPHP14 NonePHP15 NonePHP16 NonePHP17 None




PHP18 Richter Gedeon Nyrt., Budapest, HungaryPHP19 Abbott Italy, Rome, ItalyPHP20 NonePHP21 NonePHP22 Qatar National Research Fund, Doha, QatarPHP23 NonePHP24 NonePHP25 NonePHP26 The German Federal Ministry of Education and Research (BMBF), project

grant No. 01EX1013B, Bonn, GermanyPHP27 NonePHP28 NonePHP29 Cepheid, Maurens-Scopont, FrancePHP30 Institute for Health Economics and Policy, Tokyo, JapanPHP31 NonePHP32 APIFARMA, Lisboa, PortugalPHP33 APIFARMA, Lisboa, PortugalPHP34 NonePHP35 Ethicon Endo-Surgery, Norderstedt, GermanyPHP36 NonePHP37 European Commission 7 Framework Program, Brussels, BelgiumPHP38 NonePHP39 IMS HEALTH, Frankfurt/Main, GermanyPHP40 NonePHP41 European Health Technology Institute for Socio-Economic Research,

Brussels, BelgiumPHP42 NonePHP43 NonePHP44 Portuguese Pharmaceutical Industry Association, Lisbon, PortugalPHP45 NonePHP46 NonePHP47 Central Drug Research Institute, lucknow, IndiaPHP48 NonePHP49 NonePHP50 NonePHP51 Ministry of Science and Higher Education, Warsaw, PolandPHP52 HALMED, Zagreb, CroatiaPHP53 Ministry Of Health, Malaysia, Selangor, MalaysiaPHP55 NonePHP56 NonePHP57 NonePHP58 NonePHP59 NonePHP60 NonePHP61 National Institute for Health Research, London, UK; Lightfoot Solution UK

Limited, Bracknell, UKPHP62 NonePHP63 Bayer Turk, Istanbul, TurkeyPHP64 NonePHP65 NonePHP66 AusAID/ANU, Canberra, Australia; PIDE, Islamabad, PakistanPHP67 NonePHP68 NonePHP69 NonePHP70 NonePHP71 Famliy Health Research and Development Center, Kampala, UgandaPHP72 Bayer Turk, Istanbul, TurkeyPHP73 Taichung Veterans General Hospital, Taichung City, TaiwanPHP74 Apoteket AB, Stockholm, SwedenPHP75 NonePHP76 NonePHP77 NonePHP78 NonePHP79 Pfizer, Athens, GreecePHP81 F. Hoffmann-La Roche AG, Basle, SwitzerlandPHP82 KV Baden-Wuerttemberg, Stuttgart, Germany; vdek Baden-Wuerttemberg,

Stuttgart, Germany; Janssen Research Foundation, Beerse, Belgium; ShireDevelopment Inc., Wayne, PA, USA

PHP83 EFEX, Athens, GreecePHP84 EFEX, Athens, GreecePHP85 EFEX, Athens, GreecePHP86 NonePHP87 MSD, Sint Lambrechts Woluwe, BelgiumPHP88 NonePHP89 NonePHP90 NonePHP91 NonePHP92 Pfizer Hellas, Athens, GreecePHP93 NonePHP94 Indiana Office of Medicaid Policy and Planning, Indianapolis, IN, USA;

Department of Veterans Affairs, Health Services Research and Development,

Indianapolis, IN, USA; Indiana Clinical and Translational Sciences Institute,Indianapolis, IN, USA

PHP95 Novartis Hellas, Athens, GreecePHP96 NonePHP97 NonePHP98 NonePHP99 NonePHP100 Research Fellowship from Queensland Government, Brisbane, AustraliaPHP101 Novartis, Hellas, GreecePHP102 Shahid Beheshti Medical University school of pharmacy, Tehran, IranPHP103 NonePHP104 NonePHP105 NonePHP106 NonePHP107 NonePHP108 NonePHP109 NonePHP110 Santen GmbH, Germering, GermanyPHP111 ZonMw, Den Haag, NetherlandsPHP112 Novartis, Basel, SwitzerlandPHP113 NonePHP114 NonePHP115 NonePHP116 NonePHP117 NonePHP118 Novartis, basel, SwitzerlandPHP119 NonePHP120 NonePHP121 NonePHP122 Grifols Deutschland GmbH, Frankfurt, GermanyPHP123 NonePHP124 Quintiles, Hoofddorp, NetherlandsPHP125 NonePHP126 NonePHP127 NonePHP128 NonePHP130 Institute for Quality and Efficiency in Health Care, Cologne, GermanyPHP131 NonePHP132 NonePHP133 NonePHP134 NonePHP135 Pfizer, Athens, GreecePHP136 NonePHP137 NonePHP138 NonePHP139 Canadian Institutes of Health Research, Ottawa, ON, CanadaPHP140 Pfizer Pharma GmbH, Berlin, GermanyPHP141 NonePHP142 Abbott PPO, Allschwil, SwitzerlandPHP143 NonePHP144 Istanbul University, Istanbul, TurkeyPHP145 Amgen Ltd., Cambridge, UKPHP146 NonePHP147 NonePHP148 Roche Pharma, Grenzach-Wyhlen, GermanyPHP149 NonePHP150 NonePHP151 Takeda Pharmaceuticals Europe Ltd., London, UKPHP152 Pfizer Deutschland GmbH, Berlin, GermanyPHP153 NonePHP154 NonePHP155 NonePHP156 Novartis Pharma GmbH, Nuremberg, GermanyPHP157 Pfizer Deutschland GmbH, Berlin, GermanyPHP158 Pfizer Deutschland GmbH, Berlin, GermanyPHP159 NonePHP160 NonePHP161 NonePHP162 National Institute for Health and Clinical Excellence, London, UKPHP163 NonePHP164 IHS, London, UKPHP165 NonePHP167 Pfizer Deutschland GmbH, Berlin, GermanyPHP168 NonePHP169 NonePHP170 Santesuisse, Solothurn, Switzerland; Interpharma, Basel, Switzerland; FMH,

Bern, Switzerland; SAMW, Basel, SwitzerlandPHP171 NonePHP172 Agency for Healthcare Research and Quality, Rockville, MD, USAPHP173 NonePHP174 National Institutes of Health, Bethesda, MD, USA




PHP175 NonePHP176 NonePHP177 NonePHP178 NonePHP179 NonePHP180 NonePHP181 NonePHP182 Novartis, East Hanover, NJ, USAPHP183 ANF, Lisboa, PortugalPHP184 ANF, Lisboa, PortugalPHP185 ANF, Lisboa, PortugalPHP186 NonePHP187 NonePHP188 NonePHP189 Executive Insight Healthcare Consultants, Zug, SwitzerlandPHP190 NonePHP191 NonePHP192 NonePHP193 Viropharma SRL, Milano, ItalyPHP194 NonePHP195 NonePHP196 NonePHP197 PHMR Associates, London, UKPHP198 Cancer Care Ontario, Toronto, ON, CanadaPHP199 IMS Health GmbH & Co. OHG, Munich, GermanyPHP200 NonePHP201 NonePHP202 NonePHP203 NonePHP204 Department of Health, London, UKPHP205 NonePHP206 National Institute for Health Research, Leeds, UKPHS1 NonePHS2 NonePHS3 NonePHS4 NonePHS5 NonePHS6 Eli Lilly and Company, Indianapolis, IN, USAPHS7 Pfizer, Inc, NY, NY, USAPHS8 NonePHS9 NonePHS10 NonePHS11 Eli Lilly and Company, Indianapolis, IN, USAPHS12 NonePHS13 SANOFI, Barcelona, SpainPHS14 OOO ‘PAUL HARTMANN’, Moscow, RussiaPHS15 GlaxoSmithKline, Munich, GermanyPHS16 Novartis, Barcelona, SpainPHS17 ISCIII GR09/0026 GR09/0030, Madrid, SpainPHS18 Bayer Pharmaceuticals, Wayne, NJ, USAPHS19 NonePHS20 Medtronic, Madrid, SpainPHS21 NonePHS22 Pfizer, New York, NY, USAPHS23 Boehringer-Ingelheim, Mumbai, IndiaPHS24 NonePHS25 NonePHS26 GSK Biologicals, Brussels, BelgiumPHS27 NonePHS28 Sanofi UK, Guildford, UKPHS29 NonePHS30 Celgene Corporation, Summit, NJ, USAPHS31 NonePHS32 NonePHS33 Association of the Private Dialysis Centers, Istanbul, TurkeyPHS34 NonePHS35 NonePHS36 NonePHS37 NonePHS38 Centrum ter preventie van zelfdoding, Jette, BelgiumPHS39 NonePHS40 NonePHS41 NonePHS42 GlaxoSmithKline Biologicals SA, Wavre, BelgiumPHS43 Universiti Sains Malaysia, Minden, MalaysiaPHS44 NonePHS45 National Institute for Health Research, London, UKPHS46 NHMRC, Canberra, AustraliaPHS47 UBC Pharma, Brussels, BelgiumPHS48 Korea Otsuka Pharmaceutical Co., Ltd., Seoul, South KoreaPHS49 None

PHS50 Eli Lilly and Company Limited, Windlesham, UKPHS51 Sanofi, Berlin, GermanyPHS52 Fondo de Investigacion Sanitaria, Madrid, Spain; Fundacion Mutua Madrilena,

Madrid, SpainPHS53 NonePHS54 NonePHS55 Ministry of Health, Canary Islands, SpainPHS56 Novartis, Barcelona, SpainPHS57 NonePHS58 NonePHS59 NonePHS60 NonePHS61 Human Genome Sciences, Inc, Rockville, MD, USA; GlaxoSmithKline,

Research Triangle Park, NC, USAPHS62 NonePHS63 NonePHS64 NonePHS65 Astellas Pharma Global Development, Leiderdope, NetherlandsPHS66 German Federal Ministry of Health (Project ID: IIA5-2012-2512KEU305),

Bonn, GermanyPHS67 NonePHS68 UCB Pharma, Brussels, BelgiumPHS69 NonePHS70 Dpto Sanidad Gobierno Vasco , Vitoria-Gasteiz, Spain; Fondo de

Investigaciones Sanitarias, Madrid, Spain; Kronikgune, Bilbao, SpainPHS71 NonePHS72 NonePHS73 NonePHS74 Bristol-Myers Squibb, Lawrenceville, NJ, USAPHS75 Ministry of Science and Higher Education, Warsaw, Poland; Jagiellonian

University, Krakow, PolandPHS76 NonePHS77 NonePHS78 NonePHS79 Kazakh National Medical University named after S.D.Asfendiyarov, Almaty,

KazakhstanPHS80 NonePHS81 NonePHS82 AusAID/ANU, Canberra, Australia; Pakistan Institute of Development

Economics (PIDE), Islamabad, PakistanPHS83 F. Hoffmann-La Roche Ltd., Basel, SwitzerlandPHS84 Novartis Hellas, Athens, GreecePHS85 NonePHS86 NonePHS87 Novo Nordisk Pharma EAD, Sofia, BulgariaPHS88 NonePHS89 NonePHS90 Qatar University, Doha, QatarPHS92 NonePHS93 Eli Lilly and Company, Indianapolis, IN, USAPHS94 KV Baden-Wuerttemberg, Stuttgart, Germany; vdek Baden-Wuerttemberg,


PHS95 NonePHS96 National Institute for Health Research, London, UKPHS97 NonePHS98 Shire Development, LLC, Wayne, PA, USAPIH1 NonePIH2 Eli lilly Inc , Toronto, CanadaPIH3 NonePIH4 Pfizer Ltd., Surrey, UKPIH5 Qatar University, Doha, QatarPIH6 Reckitt Benckiser, Richmond, VA, USAPIH7 NonePIH8 Paul Hartmann, Moscow, RussiaPIH9 NonePIH10 Bayer Turk, Istanbul, TurkeyPIH11 Bayer Pharma AG, Berlin, GermanyPIH12 NonePIH13 NonePIH14 Bayer AB, Solna, SwedenPIH15 NonePIH16 Merck Sharp & Dohme (MSD) Israel, Ltd., Hod HaSharon, IsraelPIH17 NonePIH18 NonePIH19 H Lundbeck AB, Helsingborg, SwedenPIH20 Fresenius Kabi ELAMA , Paris, FrancePIH21 Bayer HealthCare Pharmaceuticals, Inc, Wayne, NJ, USAPIH22 NonePIH23 Fresenius Kabi Asia Pacific, Wanchai, Hong KongPIH24 Gedeon Richter Plc., Budapest, Hungary




PIH25 Bayer HealthCare Pharmaceuticals AG, Berlin, GermanyPIH26 NonePIH27 Baxter, Braine-l’Alleud, BelgiumPIH28 NonePIH29 MedImmune, Cambridge, UKPIH30 Health Research Board, Dublin, IrelandPIH31 NonePIH32 Bayer plc, Newbury, UKPIH33 NonePIH34 NonePIH35 Pfizer S.L.U., Madrid, SpainPIH36 NonePIH37 NonePIH38 Bayer plc, Newbury, UKPIH39 NonePIH40 Janssen-Cilag, Neuss, GermanyPIH41 Merck SL, Madrid, SpainPIH42 NonePIH43 Teva Pharmaceuticals, Kansas City, MO, USAPIH44 Merck Canada Inc., Kirkland, CanadaPIH45 Teva Pharmaceuticals, Kansas City, MO, USAPIH46 NonePIH47 NonePIH48 NonePIH49 Sanofi Pasteur MSD, Lyon, FrancePIH50 INC Research, LLC, Raleigh, NC, USAPIH51 NonePIN1 NCDC, Tripoli, LibyaPIN2 Sanofi Pasteur, Lyon, FrancePIN3 Astellas Pharma B.V., Leiderdorp, NetherlandsPIN4 Pfizer Inc, New York, NY, USAPIN5 AstraZeneca, Macclesfield, UKPIN6 NonePIN7 AstraZeneca, Macclesfield, UKPIN8 NonePIN9 Agency for Healthcare Research and Quality, Rockville, MD, USA;

Genentech, South San Francisco, CA, USAPIN10 GlaxoSmithKline Biologicals SA, Rixensart, BelgiumPIN11 NonePIN12 Pfizer, Collegeville, PA, USAPIN13 Pfizer, Collegeville, PA, USAPIN14 MSD Sharp & Dohme GmbH, Haar, Germany; Merck & Co, Inc., Whitehouse

Station, PA, USAPIN15 Sanofi, Chilly-Mazarin, FrancePIN16 NonePIN17 NonePIN18 Johnson & Johnson, Horsham, PA, USAPIN19 Sanofi Pasteur MSD, Maidenhead, UKPIN20 ViiV Healthcare, Verona, ItalyPIN21 sanofi, Chilly-Mazarin, FrancePIN22 Pfizer Oy, Helsinki, FinlandPIN23 Bristol-Meyer Squinn, Madrid, SpainPIN24 Pfizer Spain, Madrid, SpainPIN25 Pfizer Animal Health Inc., Madison, NJ, USAPIN26 MSD Pharma Hungary Ltd., Budapest, HungaryPIN27 Pfizer International Operations, Paris, FrancePIN28 Pfizer Pharma GmbH, Berlin, GermanyPIN29 Astellas, Espoo, FinlandPIN30 NonePIN31 Expanded Program on Immunization, Colombian Ministry of Health and

Social Protection, Bogota, ColombiaPIN32 MSD Pharma Hungary Kft., Budapest, HungaryPIN33 Janssen Cilag, Neuss, GermanyPIN34 Merck Sharp Dohme/Merck, Munchen, GermanyPIN35 National Research Foundation (NRF), Pretoria, South AfricaPIN36 NonePIN37 Pfizer Hellas, Athens, GreecePIN38 Astellas S.A, Athens, GreecePIN39 GlaxoSmithKline Biologicals SA. , Rixensart, BelgiumPIN40 MSD Sharp Dohme GmbH, Haar, Germany; Merck & Co Inc., Whitehouse

Station, NJ, USAPIN41 NonePIN42 Janssen, Vienna, AustriaPIN43 Janssen-Cilag S.A., MADRID, SpainPIN44 MSD, Athens, GreecePIN45 GlaxoSmithKline Biologicals SA, Rixensart, BelgiumPIN46 GlaxoSmithKline, Italy, Verona, ItalyPIN47 GlaxoSmithKline, Bratislava, Slovak RepublicPIN48 NonePIN49 Pfizer Brazil, Sao Paulo, BrazilPIN50 Janssen Cilag Pharmaceutical SACI, Athens, Greece

PIN51 NonePIN52 NonePIN53 Health Research Board, Dublin, Ireland; Department of Foreign Affairs,

Dublin, IrelandPIN54 NonePIN55 Janssen, Madrid, SpainPIN56 J&J, Beerse, BelgiumPIN57 Pfizer Brazil, Sao Paulo, BrazilPIN58 Janssen Cilag, Sao Paulo, BrazilPIN59 GlaxoSmithKline, Ystanbul, TurkeyPIN60 Sanofi Pasteur MSD, Lyon, FrancePIN61 Janssen-Cilag B.V., Tilburg, NetherlandsPIN62 Janssen-Cilag, Neuss, GermanyPIN63 sanofi pasteur MSD, Lyon, FrancePIN64 Sanofi Pasteur MSD, Maidenhead, EnglandPIN65 Abbott Labs, Abbott Park, IL, USAPIN66 Pfizer inc., Sao Paulo, BrazilPIN67 Pfizer inc., Sao Paulo, BrazilPIN68 Merck Sharp & Dohme BV, Haarlem, NetherlandsPIN69 Pfizer Inc, New York City, NY, USAPIN70 Roche Spa, Monza, ItalyPIN71 GlaxoSmithKline Biologicals SA, Wavre, BelgiumPIN72 NonePIN73 Merck, Sharp & Dohme, Paco de Arcos, PortugalPIN74 NonePIN75 StAstellas Pharma Europe Inc., Stains, UKPIN76 NonePIN77 Astellas Pharma Global Development, Leiderdorp, NetherlandsPIN78 Baxter Healthcare Corporation, Zurich, SwitzerlandPIN79 NonePIN80 Bristol-Myers Squibb, Ruel Malmaison, FrancePIN81 NonePIN82 GlaxoSmithKline Biologicals SA. , Rixensart, BelgiumPIN83 NonePIN84 NonePIN85 NonePIN86 GlaxoSmithKline Biologicals SA, Wavre, BelgiumPIN87 Astellas Pharma, Kastrup, DenmarkPIN88 NonePIN89 GlaxoSmithKline, Munich, GermanyPIN90 Sanofi pasteur MSD, LYON, FrancePMD1 Teva Neuroscience, Kansas City, MO, USAPMD2 Novartis Molecular Diagnostics, Cambridge, MA, USAPMD3 NonePMD4 astrazeneca, rueil malmaison, FrancePMD5 Agency for Health Technology Assessment In Poland (AHTAPol), Warsaw,

PolandPMD6 Therakos (J&J Affiliate), Wokingham, UKPMD8 Allergan, Inc., Irvine, CA, USAPMD9 Boston Scientific, Natick, MA, USAPMD10 Boston Scientific, Natick, MA, USAPMD11 BD Diagnostics, Oxford, UKPMD12 Becton Dickinson UK Ltd., Oxford, UKPMD13 St. Jude Medical, St. Paul, MN, USAPMD14 Covidien, Istanbul, TurkeyPMD15 NonePMD16 Tillotts Pharma AG, Rheinfelden, SwitzerlandPMD17 Ethicon Endo-Surgery (Europe) GmbH, Norderstedt, GermanyPMD18 Fujirebio Diagnostics, Malvern, PA, USAPMD19 Acclarent Inc, Menlo Park, CA, USAPMD20 Medtronic Vascular Inc., Santa Rosa, CA, USAPMD21 Medtronic Trading Sarl., Tolochenaz, SwitzerlandPMD22 Medtronic, Lisbon, PortugalPMD23 Medtronic Ardian LLC, Mountain View, CA, USAPMD24 Therakos (J&J Affiliate), Wokingham, PolandPMD25 Medtronic, Mounds View, MN, USAPMD26 National Institute for Health Research (NIHR) Collaboration for Leadership in

Applied Health Research and Care (CLAHRC) for Northwest London, London,UK

PMD27 Medtronic, Inc., Mounds View, MN, USAPMD28 Bayer Healthcare, Berlin, GermanyPMD29 NonePMD30 Roche Diagnostics GmbH, Mannheim, GermanyPMD31 NonePMD32 Sorin Group, Saluggia, ItalyPMD33 Bayer HealthCare Medical Care, Berlin, GermanyPMD34 NonePMD35 Medtronic Iberica, Madrid, SpainPMD36 Becton Dickinson, Heidelberg, GermanyPMD37 Biosense Webster, Diamond Bar, CA, USAPMD38 Medtronic International, Tolochenaz, Switzerland




PMD39 Biosense Webster, Diamond Bar, CA, USAPMD40 Johnson & Johnson, Singapore, SingaporePMD41 NonePMD42 National Evidence-based Collaborating Agency, Seoul, South KoreaPMD43 Synthes, Zuchwil, SwitzerlandPMD44 American Society of Gastrointestinal Endoscopy, Oak Brook, IL, USAPMD45 GE Healthcare, Chalfont St Giles, Buckinghamshire, UKPMD46 GE Healthcare, Chalfont St Giles, Buckinghamshire, UKPMD47 GE Healthcare, Chalfont St Giles, Buckinghamshire, UKPMD48 NonePMD49 Urgo, Chenove, FrancePMD50 NonePMD51 Genomic Health, Geneva, SwitzerlandPMD52 National Institute for Health Research, London, UKPMD53 LifeScan, Inc., West Chester, PA, USAPMD54 NonePMD55 Medtronic , Tolochenaz, SwitzerlandPMD56 NonePMD57 3m Nederland, zoeterwoude, NetherlandsPMD58 Netherlands Leprosy Relief, Jos, NigeriaPMD60 3m Nederland, zoeterwoude, NetherlandsPMD61 The Center for Translational Molecular Medicine (Project AIRFORCE),

Eindhoven, NetherlandsPMD62 Thermo Fisher Scientific, Uppsala, SwedenPMD63 Center for Translational Molecular Medicine and the Netherlands Heart

Foundation (COHFAR), Utrecht, NetherlandsPMD64 Thermo Fisher Scientific, Uppsala, SwedenPMD65 GEHC, London, UKPMD66 Perouse medical, Ivry le temple, FrancePMD67 NonePMD68 Medtronic Italia, Sesto San Giovanni, ItalyPMD69 Biosense Webster, Diamond Bar, CA, USAPMD70 Salix Pharmaceuticals, Raleigh, NC, USAPMD71 Medtronic, Tolochenaz, SwitzerlandPMD72 NonePMD73 Instituto de salud Carlos III, Madrid, SpainPMD74 NonePMD75 CTMM, Eindhoven, NetherlandsPMD76 NonePMD77 Medtronic SARL, Tolochenaz, SwitzerlandPMD78 Medtronic, Tolochenaz, SwitzerlandPMD79 Sanofi, Laval, QC, CanadaPMD80 NonePMD81 Novo Nordisk A/S, Bagsvaerd, DenmarkPMD82 Medtronic Italia SpA, Sesto San Giovanni (MI), ItalyPMD83 NonePMD84 National institute for Health Research , Southampton, UKPMD85 GE Healthcare, Wauwatosa, WI, USAPMD86 NonePMD88 AstraZeneca, Wedel, GermanyPMD89 UK NETSCC, London, UKPMD90 NonePMD91 NonePMD92 Mundipharma International Ltd., Cambridge, UKPMD93 NonePMH1 NonePMH2 Eli Lilly and Company, Indianapolis, IN, USAPMH3 National Health and Medical Research Council (NHMRC, Australian

Government, Melbourne, Australia; Australian Rotary Health, Melbourne,Australia

PMH4 Janssen Cilag, Beerse, BelgiumPMH5 Shire Pharmaceuticals LLC, Wayne, PA, USAPMH6 Lundbeck SAS, Issy-les-Moulineaux, FrancePMH7 Swedish Lundbeck foundation , Helsingborg, SwedenPMH8 National Research Foundation (NRF), Pretoria, South AfricaPMH9 NonePMH10 Reckitt Benckiser, Richmond, VA, USAPMH11 Janssen-Cilag BV, Tilburg, NetherlandsPMH12 NonePMH13 Eli Lilly and Company, Indianapolis, IN, USAPMH14 Pfizer Inc., Walton Oaks, London, UKPMH15 Bristol Myers-Squibb, Uxbridge, UKPMH16 NonePMH17 Takeda Pharmaceuticals Europe, London, UKPMH18 Janssen Cilag, Neuss, GermanyPMH19 University Medical Center Groningen, Groningen, Netherlands; Rob Giel

Research Center, Groningen, Netherlands; UitvoeringsinstituutWerknemersverzekeringen (UWV), Utrecht, Netherlands; Trimbos Institute,Utrecht, Netherlands; University Center of Psychiatry, Groningen,Netherlands

PMH20 Lundbeck, Paris, France

PMH21 Pfizer S.A. de C.V., Mexico City, MexicoPMH22 Janssen Cilag, Beerse, BelgiumPMH23 Janssen Cilag, Beerse, BelgiumPMH24 NonePMH25 Lundbeck SAS, Issy les Moulineaux, FrancePMH26 NonePMH27 Lundbeck Italia S.p.A., Milan, ItalyPMH28 Janssen de Mexico, Mexico, MexicoPMH29 AstraZeneca, Mexico, MexicoPMH30 Janssen, Vienna, AustriaPMH31 NonePMH32 Janssen, Beerse, BelgiumPMH33 NonePMH34 University of South Carolina, Columbia, SC, USA; Greenville HospitalPMH35 NonePMH36 Janssen Cilag, Beerse, BelgiumPMH37 Shire Pharmaceuticals, Wayne, PA, USAPMH38 AstraZeneca Spain, Madrid, SpainPMH39 Pfizer Inc., New York, NY, USA; Abbott Laboratories, Abbott Park, IL, USA;

Eli Lilly & Company, Indianapolis, IN, USA; Bristol-Myers Squibb Company,Wallingford, CT, USA; Forest Laboratories, Jersey City, NJ, USA; SunovionPharmaceuticals Inc., Marlborough, MA, USA; Shire Development Inc.,Wayne, PA, USA; Janssen Global Services, LLC, Raritan, NJ, USA

PMH40 Abbott Laboratories, Abbott Park, IL, USA; Eli Lilly and Company,Indianapolis, IL, USA; Forest Laboratories, Jersey City, NJ, USA; JanssenGlobal Services, Raritan, NJ, USA; Bristol-Myers Squibb Company,Wallingford, CT, USA; Shire Development, Inc., Wayne, PA, USA; Pfizer Inc.,New York, NY, USA; Sunovion Pharmaceuticals Inc., Marlborough, MA, USA

PMH41 National Evidence-based Healthcare Collaborating Agency, Seoul, SouthKorea

PMH42 lundbeck SAS, Issy-les-Moulineaux, FrancePMH43 Pfizer S.L.U., Madrid, SpainPMH44 Janssen-Cilag B.V, Tilburg, NetherlandsPMH45 Takeda, London, UKPMH46 Ministry of Health, Labour and Welfare, Tokyo, JapanPMH47 Janssen Cilag, Beerse, BelgiumPMH48 NonePMH49 The research is supported by the German Federal Ministry of Education and

Research (BMBF), project grant No. 01EX1013B as part of the Centre ofExcellence for Medical Technology., Bonn, Germany

PMH50 AstraZeneca, Södertälje, SwedenPMH51 IMS Health, Stockholm, SwedenPMH52 Shire Pharmaceuticals Inc., Wayne, PA, USAPMH53 NonePMH54 Eli Lilly and Company, Indianapolis, IN, USAPMH55 NonePMH56 KV Baden-Wuerttemberg, Stuttgart, Germany; vdek Baden-Wuerttemberg,


PMH57 Quintiles, Hoofddorp, NetherlandsPMH58 Shire Pharmaceuticals LLC, Wayne, PA, USAPMS1 NonePMS2 Novo Nordisk A/S, Bagsværd, DenmarkPMS3 Novo Nordisk A/S, Bagsværd, DenmarkPMS4 Bristol-Myers Squibb, Paris, FrancePMS5 Abbott Laboratories, Abbott Park, IL, USAPMS6 Merck & Co. Inc, Whitehouse Station, NJ, USAPMS7 NonePMS8 NonePMS9 Merck Sharp & Dohme S.A., Athens, GreecePMS10 Abbott, Rungis, FrancePMS11 Pfizer Spain, Madrid, SpainPMS12 Janssen Cilag, Sao Paulo, BrazilPMS13 NonePMS14 NonePMS15 NonePMS16 Bristol-Myers Squibb, Moscow, RussiaPMS17 NonePMS18 NonePMS19 Pfizer Pharmaceuticals, Istanbul, TurkeyPMS20 NonePMS21 NonePMS22 Pfizer Pharmaceuticals, Istanbul, TurkeyPMS23 NonePMS24 Pfizer, spol. s r.o., Prague, Czech RepublicPMS25 UCB Pharma, Colombes, FrancePMS26 UCB Pharma, Colombes, FrancePMS27 Sanquin, Espoo, FinlandPMS28 NonePMS29 Abbott Italy, Rome, ItalyPMS30 Roche Farma, Madrid, Spain




PMS31 Abbott Italy, Rome, ItalyPMS32 NonePMS33 Roche Farmaceutica Quımica Lda., Amadora, PortugalPMS34 NonePMS35 Roche, Istanbul, TurkeyPMS36 Amgen, Zug, SwitzerlandPMS37 Abbott Laboratories, Abbott Park, IL, USAPMS38 Grunenthal GmbH, Aachen, GermanyPMS39 AstraZeneca, Sao Paulo, BrazilPMS40 Amgen , Thousand Oaks, CA, USAPMS41 GlaxoSmithKline, Rio de janeiro, BrazilPMS42 Roche Farmaceutica Quımica, Lda., Amadora, PortugalPMS43 Genentech, South San Francisco, CA, USAPMS44 The Ministry of Education, Science, Sports and Culture, Tokyo, JapanPMS45 Health Research Council of New Zealand, Auckland, New ZealandPMS46 Abbott Italy, Rome, ItalyPMS47 Abbott Australasia, Sydney, AustraliaPMS48 Roche Products Limited, Welwyn Garden City, UKPMS49 Pfizer S.A., Madrid, SpainPMS50 NonePMS51 NonePMS52 Roche Brazil, Sao Paulo, BrazilPMS53 Eli Lilly and Company, Indianapolis, IN, USAPMS54 Amgen (Europe) GmbH, Zug, SwitzerlandPMS55 Amgen (Europe) GmbH, Zug, SwitzerlandPMS56 Amgen (Europe) GmbH, Zug, SwitzerlandPMS57 Amgen, Paco D’arcos, PortugalPMS58 Merck & Co., Inc., Whitehouse Station, NJ, USAPMS59 NonePMS60 Eli Lilly and Company, Indianapolis, IN, USAPMS61 IOF Invest in Your Bones (IYB), Nyon, Switzerland; Amgen, Thousand Oaks,

CA, USA; Eli Lilly, Indianapolis, IN, USA; Medtronic, Minneapolis, MN, USA;Novartis, Basel, Switzerland; Sanofi, Paris, France; Servier, Neuilly-sur-Seine,France; Pfizer, New York, NY, USA

PMS62 Amgen, Zug, SwitzerlandPMS63 NonePMS64 Genentech, South San Francisco, CA, USAPMS65 Pfizer Ltd. UK, Kingston upon Thames, UKPMS66 NIH, Bethesda, MD, USA; MDA, Tucson, AZ, USAPMS67 UCB Pharma, Brussels, BelgiumPMS68 NonePMS69 MedImmune Limited, Cambridge, UKPMS70 Eli Lilly and Company, Indianapolis, IN, USAPMS71 Eli Lilly and Company, Indianapolis, IN, USAPMS72 Eli Lilly and Company, Indianapolis, IN, USAPMS73 NonePMS74 NonePMS75 Genentech, Inc., South San Francisco, CA, USAPMS76 Merck, Sharp & Dohme, Paco de Arcos, PortugalPMS77 Eli Lilly and Company, Indianapolis, IN, USAPMS78 NonePMS79 Quintiles, Hoofddorp, NetherlandsPMS80 NonePMS81 UCB Pharma Oy Finland, Espoo, FinlandPMS82 Celgene Corporation, Warren, NJ, USAPND1 Lundbeck SAS, Issy-Les-Moulineaux, FrancePND2 NonePND3 Biogen Idec Inc, Weston, MA, USAPND4 Astellas Pharma Europe Ltd., Staines, UKPND5 UCB Pharma, Brussels, BelgiumPND6 NonePND7 NonePND8 NonePND9 Sanofi, Berlin, GermanyPND10 NonePND11 Vertex, Cambridge, MA, USAPND12 Ferrer Grupo, Barcelona, SpainPND13 Alfa Wasserman, Mexico, MexicoPND14 Transfer Office Research Findings, Malaga, SpainPND15 Viropharma SRL, Milano, ItalyPND16 UCB de Mexico, Polanco, MexicoPND17 NonePND18 NonePND19 NonePND20 Lundbeck SAS, Issy-Les-Moulineaux, FrancePND21 NonePND22 NonePND23 Bayer Healthcare, Berlin, GermanyPND24 NonePND25 Bayer Healthcare, Berlin, GermanyPND26 Almirall Hermal GmbH, Reinbek, Germany

PND27 Merck SL, Madrid, SpainPND28 Sanofi, Berlin, GermanyPND29 NonePND30 TEVA Pharma, Madrid, SpainPND31 Teva Neuroscience, Kansas City, MO, USAPND32 Stendhal, Mexico, MexicoPND33 Ferrer Grupo, Barcelona, SpainPND34 Teva Pharmaceuticals, Malvern, PA, USAPND35 ViroPharma SPRL-BVBA, Brussels, BelgiumPND36 NonePND37 Viropharma SRL, Milano, ItalyPND38 Novartis Farmaceutica S.A., Barcelona, SpainPND39 Direction Generale de l’Organisation des Soins, Paris, FrancePND40 Novartis, Sao Paulo, BrazilPND41 ViroPharma Europe, London, UKPND42 Allergan Inc., Rome, ItalyPND43 NonePND44 Sanofi Polska , Warsaw, PolandPND45 Eisai, Inc, Woodcliff Lake, NJ, USAPND46 Novartis Farmaceutica, S.A., Barcelona, SpainPND47 NSW Department of Health, Sydney, AustraliaPND48 Eli Lilly and Company, Windlesham, UKPND49 NonePND50 Acorda Therapeutics, Hawthorne, NY, USAPND51 Viropharma SRL, Milano, ItalyPND52 NonePND53 NonePND54 Almirall Hermal GmbH, Reinbek, GermanyPND55 Biogen Idec, Weston, MA, USAPND56 Novartis Farmaceutica, S.A., Barcelona, SpainPND57 NonePND58 Biogen Idec Inc, Weston, MA, USAPND59 NeuroSearch A/S, Ballerup, DenmarkPND60 Center for Public Affairs Studies Foundation, Budapest, HungaryPND61 NeuroSearch A/S, Ballerup, DenmarkPND62 European Federation of Neurological Associations, Brussels, BelgiumPND63 Biogen Idec Inc, Weston, MA, USAPND64 ViroPharma SPRL, Brussels, BelgiumPND65 Novartis Farmaceutica, S.A., Barcelona, SpainPND66 NonePND67 Lundbeck Canada, Montreal, QC, CanadaPND68 Teva Pharmaceuticals, Kansas City, MO, USAPND69 Shire HGT, Eysins, SwitzerlandPND70 Teva Pharmaceuticals, Kansas City, MO, USAPND71 Teva, Kansas City, MO, USAPND72 NonePND73 Merck Serono, Darmstadt, GermanyPND74 NonePRM1 NonePRM2 Bristol-Myers Squibb, Lawrenceville, NJ, USAPRM3 CVZ (Dutch Health Care Insurance Board), Diemen, NetherlandsPRM4 NonePRM5 Roche Pharma, Grenzach-Wyhlen, GermanyPRM6 NonePRM7 Boehringer Ingelheim GmbH, Ingelheim/Rhein, GermanyPRM8 Pfizer Deutschland GmbH, Berlin, GermanyPRM9 Sanofi Pasteur, Lyon, FrancePRM10 South Central VA Health Care Network, Jackson, MS, USAPRM11 Amgen, Breda, Netherlands; Merck-Serono, Amsterdam, NetherlandsPRM12 NonePRM13 Pharmaceutical Oncology Initiative, London, UK; National Institute for Health

Research, London, UKPRM14 European Commission, Brussels, BelgiumPRM15 WHO - Initiative for Vaccine Research, Geneva, SwitzerlandPRM16 NonePRM17 sanofi pasteur MSD, Lyon, FrancePRM18 NonePRM19 Department of Health, UK, London, UKPRM20 German Federal Ministry of Education and Research, Berlin, GermanyPRM21 NonePRM22 The authors acknowledge funding from the EPSRC under the MATCH

Programme (grants GR/S29874/01, EP/F063822/1 & EP/G012393/1),Uxbridge, UK

PRM23 Medical Research Council, London, UKPRM24 NonePRM25 National Institute for Health Research, London, UKPRM26 NonePRM27 Novo Nordisk, Zurich, SwitzerlandPRM28 Cegedim Strategic Data Medical Research UK, London, UK; Medical

Research Council, London, UKPRM29 GlaxoSmithKline, Rio de Janeiro, Brazil




PRM30 GlaxoSmithKline, Rio de Janeiro, BrazilPRM31 NonePRM32 NonePRM33 PHMR Associates, London, UKPRM34 FFG, Vienna, Austria; Main Association of Austrian Social Security

Organisations, Vienna, AustriaPRM35 Pfizer Pharma GmbH, Berlin, GermanyPRM36 NonePRM37 NonePRM38 Abbott Scandinavia AB, Solna, SwedenPRM39 Bristol-Myers Squibb, Rueil, FrancePRM40 NonePRM41 Janssen Scientific Affairs, LLC, Raritan, NJ, USAPRM42 NonePRM43 NonePRM44 NonePRM45 ThromboGenics NV, Heverlee, BelgiumPRM46 GlaxoSmithKline, Zeist, NetherlandsPRM47 Agency for Healthcare Research and Quality, Rockville, MD, USAPRM48 NonePRM49 NonePRM50 NonePRM52 NonePRM53 ALK-Abello A/S, Hoersholm, DenmarkPRM54 NonePRM55 NonePRM56 GlaxoSmithKline R&D, Uxbridge, UKPRM57 Merck and Co., Inc., North Wales, PA, USAPRM58 NonePRM59 NonePRM60 NIHR, London, UKPRM61 BMBF, Berlin, GermanyPRM62 NonePRM63 ALK-Abello A/S, Hoersholm, DenmarkPRM64 NonePRM65 The Netherlands Organisation for Scientific Research, The Hague,

NetherlandsPRM66 NonePRM67 NonePRM68 NonePRM69 NonePRM70 Medical Research Council, London, UKPRM71 NonePRM72 NonePRM73 Roche Products Limited, Welwyn Garden City, UKPRM74 Iroko Pharmaceuticals Llc., Philadelphia, PA, USAPRM75 NonePRM76 GSK, Brentford, UKPRM77 NonePRM78 Novartis, Basel, SwitzerlandPRM79 NonePRM80 HTA Consulting, Krakow, PolandPRM81 NonePRM82 HTA Consulting, Krakow, PolandPRM83 Netherlands Organization for Health Research and Development (ZonMW),

The Hague, NetherlandsPRM84 NonePRM85 NonePRM86 Sanofi, Cambridge, MA, USAPRM87 NonePRM88 NonePRM89 NIH, Washington DC, DC, USAPRM90 Novo Nordisk A/S, Bagsværd, DenmarkPRM91 NonePRM92 NonePRM93 PFSA, Boulogne, FrancePRM94 NonePRM95 GlaxoSmithKline, Tres Cantos (Madrid), SpainPRM96 Top Institute Pharma, Leiden, NetherlandsPRM97 NonePRM98 NonePRM99 NonePRM100 Fresenius Biotech GmbH, Munchen, GermanyPRM101 Research Fellowship from Queensland Government, Brisbane, AustraliaPRM102 NonePRM103 NonePRM104 PharmIdeas Research and Consulting, Ottawa, ON, CanadaPRM105 Pfizer S.L.U., Madrid, SpainPRM106 PharmIdeas Research and Consulting, Ottawa, ON, CanadaPRM107 NonePRM108 Astellas Pharma Global Development, Leiderdorp, Netherlands

PRM109 F. Hoffmann-La Roche Ltd., Basel, SwitzerlandPRM110 NonePRM111 Advanced BioHealing Inc., La Jolla, CA, USAPRM112 NonePRM113 NonePRM114 NonePRM115 NonePRM116 Quintiles, Hoofddorp, NetherlandsPRM117 CRF Health, London, UKPRM118 NonePRM119 NonePRM120 NonePRM121 PFSA, Boulogne, FrancePRM122 PFSA, Boulogne, FrancePRM124 NonePRM125 Flinders University, Bedford Park, Australia; National Health and Medical

Research Council (NHMRC), Canberra, AustraliaPRM126 National Cancer Institute, Bethesda, MD, USAPRM127 NonePRM128 NonePRM129 NonePRM130 NonePRM131 NonePRM132 Novo Nordisk A/S, Soborg, DenmarkPRM133 NonePRM134 German Federal Ministry of Education and Research, Bonn, GermanyPRM135 Departamento Sanidad Gobierno Vasco, Vitoria-Gasteiz, Spain; Instituto de

Salud Carlos III (FIS), Madrid, Spain; Kronikgune, Bilbao, SpainPRM136 NonePRM137 Merck Research Labs, Blue Bell, PA, USAPRM138 NonePRM139 Genentech, Inc., South San Francisco, CA, USAPRM140 NonePRM141 ThromboGenics, Heverlee, BelgiumPRM142 F. Hoffmann-La Roche Ltd., Basel, SwitzerlandPRM143 the European Union Seventh Framework Programme, Bruxelles, Belgium;

Canceropole Lyon Auvergne Rhone-Alpes CLARA, Lyon, France; MerckSerono, Lyon, France

PRM144 NonePRM145 Eli Lilly and Company, Indianapolis, IN, USAPRM146 NonePRM147 NonePRM148 NonePRM149 NonePRM150 NonePRM151 NonePRM152 NonePRM153 Novartis Pharma GmbH, Nurnberg, GermanyPRM154 PPD, Morrisville, NC, USAPRM155 Jagiellonian University Medical College, Cracow, PolandPRM156 NonePRM157 NonePRM158 NonePRM159 NonePRM160 NonePRM161 GlaxoSmithKline Biologicals SA. , Rixensart, BelgiumPRM162 Roche, Grenzach-Wyhlen, GermanyPRM163 NonePRM164 NonePRM165 GSK, uxbridge, UKPRM166 NonePRM167 NonePRM168 MRC NIHR, London, UKPRM169 Dr. Willmar Schwabe Pharmaceuticals, Karlsruhe, GermanyPRM170 GSK Vaccines, Wavre, BelgiumPRM171 NonePRM172 NonePRM173 NonePRM174 PhRMA Foundation, Washington, DC, USAPRM175 NonePRM176 NonePRM177 CTMM, the Center for Translational Molecular Medicine, Eindhoven,

NetherlandsPRM178 NonePRS1 NonePRS2 Takeda Pharmaceuticals Korea Co., Ltd., Seoul, South KoreaPRS3 Novartis, Basel, SwitzerlandPRS4 Almirall S.A., Barcelona, Spain; Forest Research Institute Inc., Jersey City,

NJ, USAPRS5 Novartis Pharam AG, Basel, Switzerland; Novartis Pharmaceutical UK

Limited, Horsham, UK




PRS6 NonePRS7 Teva Pharmaceuticals, Horsham, PA, USAPRS8 Novartis Pharma AG, Basel, SwitzerlandPRS9 German Dermatology Society DDG, Berlin, GermanyPRS10 NonePRS11 Abbott, Abbott Park, IL, USAPRS13 NonePRS14 Stallergenes CZ, Bratislava, Slovak RepublicPRS15 Asthma Fund, Amersfoort, Netherlands; Novartis, Arnhem, NetherlandsPRS16 NonePRS17 NonePRS18 Novartis Pharma AG, Basel, SwitzerlandPRS19 NonePRS20 United Therapeutics Corporation, Research Triangle Park, NC, USAPRS21 AstraZeneca, Södertälje, SwedenPRS22 Pfizer S.L.U., Madrid, SpainPRS23 Nycomed: a Taceda company, Moscow, RussiaPRS24 Pfizer, Vienna, AustriaPRS25 Novartis, Mexico City, MexicoPRS26 Novartis, Sao Paulo, BrazilPRS27 Gedeon Rihter Belarusian Branch, Budapest, HungaryPRS28 Gedeon Rihter Belarusian Branch, Budapest, HungaryPRS29 NonePRS30 Nestle Nutrition Institute, VEVEY, SwitzerlandPRS31 NonePRS32 The University of Southern Denmark, Odense, Denmark; The Ministry of

Science, Technology and Innovation, Copenhagen, Denmark; ALK Abello A/S, Hørsholm, Denmark; Aalborg University, Aalborg, Denmark

PRS33 Kantar Health, Princeton, NJ, USAPRS34 Boehringer Ingelheim Pty Limited, Sydney, AustraliaPRS35 ViroPharma SPRL-BVBA, Brussels, BelgiumPRS36 Boehringer Ingelheim GmnH, Ingelheim, GermanyPRS37 NonePRS38 Baskent University, Ankara, TurkeyPRS39 United Therapeutics Corporation, Research Triangle Park, NC, USAPRS40 Achmea, Zeist, NetherlandsPRS41 Abbott laboratories, Abbott Park, IL, USAPRS42 GlaxoSmithKline, Munich, GermanyPRS43 Novartis Finland Oy, Espoo, FinlandPRS44 NonePRS45 NonePRS46 Vertex Pharmaceuticals Incorporated, Cambridge, MA, USAPRS47 Mundipharma International Ltd., Cambridge, UKPR1 NonePR2 NonePR3 NonePR4 OptumInsight, Eden Prairie, MN, USAPSS1 NonePSS2 NIHR HTA Programme (project number 09/132), Southampton, UKPSS3 NonePSS4 PFD, Lavaur, FrancePSS5 Ministry of Health, Brasilia, BrazilPSS6 Medi, Bayreuth, GermanyPSS7 Novartis Pharmaceuticals Canada Inc, Dorval, QC, CanadaPSS8 N.V. Novartis Pharma S.A., Vilvoorde, BelgiumPSS9 Pfizer Luxembourg SARL, oz, Bratislava, Slovak Republic, Bratislava, Slovak

RepublicPSS10 Novartis Pharma GmbH, Nurnberg, GermanyPSS11 Abbott Italy, Rome, ItalyPSS12 Alcon, Camberley, UKPSS13 Netherlands Organisation for , The Hague, NetherlandsPSS14 Abbott Laboratories, Abbott Park, IL, USAPSS15 NonePSS16 Astellas Pharma Europe, Staines, UKPSS17 Pfizer, Sao Paulo, BrazilPSS18 Novartis Pharma AG, Basel, SwitzerlandPSS19 Novartis Pharmaceuticals Canada Inc., Dorval, QC, CanadaPSS20 Genentech, Inc., South San Francisco, CA, USAPSS21 Novartis Pharma Canada, Montreal, QC, CanadaPSS22 Janssen, High Wycombe, UKPSS23 Janssen, High Wycombe, UKPSS24 NonePSS25 NonePSS26 Schering-Plough Corporation, Kenilworth, NJ, USAPSS27 Pfizer, Inc, New York, NY, USAPSS28 Janssen, High Wycombe, UKPSS29 Allergan, Inc., Irvine, CA, USAPSS30 pfsa, Boulogne, FrancePSS31 NonePSS32 Merck & Co, Inc, Whitehouse Station, NJ, USAPSS33 Amgen Inc, Thousand Oaks, CA, USA

PSS34 Biersdorf UK Ltd., Birmingham, UKPSS35 Novartis Pharmaceuticals Canada Inc, Dorval, QC, CanadaPSU1 Ethicon Endo Surgery (Europe) GmbH, Norderstedt, GermanyPSU2 National Evidence-based Healthcare Collaborating Agency, Seoul, South

KoreaPSU3 Monash University, Melbourne, Australia; National Heart Foundation of

Australia Postgraduate Research Scholarship (PC 10M 5457), Melbourne,Australia

PSU4 NonePSU5 NonePSU6 NonePSU7 NonePSU8 Johnson & Johnson , Madrid, SpainPSU9 BioMimetic Therapeutics, Inc, Franklin, TN, USAPSU10 National Heart Foundation, Australia; Abbott,Australia; Schering-Plough,

Australia; Servier, Australia; Sanofi-Aventis, Australia; Pfizer, Australia; MSD,Australia; Medtronic, Australia; CSL, Australia; Cordis Johnson & Johnson,Australia; Bristol-Myers Squibb, Australia; Boston Scientific, Australia;Biotronik, Australia; Astra-Zeneca, Australia; National Health and MedicalResearch Council, Australia

PSU11 Amgen Inc, Thousand Oaks, CA, USAPSU12 Medtronic, Tolochenaz, SwitzerlandPSU13 Medtronic, Inc., Tolochenaz, SwitzerlandPSU14 NonePSU15 Ethicon, Inc, Somerville, NJ, USAPSU16 NonePSU17 SANOFI AVENTIS, SAO PAULO, BrazilPSU18 Amgen UK & Ireland, Uxbridge, UKPSU19 NonePSU20 Medtronic International, Tolochenaz, SwitzerlandPSU21 Haute Autorite de sante, Saint-Denis La Plaine, FrancePSU22 Amgen AB, Helsinki, FinlandPSU23 NonePSU24 NonePSU25 Medtronic SARL, Tolochenaz, SwitzerlandPSU26 Pfizer Brasil, Rio de Janeiro, BrazilPSU27 Pfizer Brazil, Sao Paulo, BrazilPSU28 Pfizer Brazil, Sao Paulo, BrazilPSU29 ViforPharma, Neuilly-sur-Seine, FrancePSU30 Bayer Turk, Istanbul, TurkeyPSU31 Medtronic Spinal & Biologics, Memphis, TN, USAPSU32 Medtronic Spinal and Biologics, Memphis, TN, USAPSU33 Novartis Corporation, East Hanover, NJ, USAPSU34 Novartis Pharma GmbH, Nuremberg, GermanyPSU35 Novartis Pharma GmbH, Nuremberg, GermanyPSU36 DePuy Mitek, Raynham, MA, USAPSY1 NonePSY2 Roche Farma SA, Madrid, SpainPSY3 GlaxoSmithKline, Research Triangle Park, NC, USA; Human Genome

Sciences, Rockville, MD, USAPSY4 Celgene Corporation, Summit, NJ, USAPSY5 Millennium Pharmaceuticals, Inc, Cambridge, MA, USAPSY6 OM Pharma, Lisbon, PortugalPSY7 Adelphi Real World, Bollington, UKPSY8 Novartis, Hellas, GreecePSY9 Pfizer Inc, Walton Oaks, London, UKPSY10 Shire HGT, Basingstoke, UKPSY11 Novo Nordisk Scandinavia AB, Malmö, SwedenPSY12 Novartis, Hellas, GreecePSY13 NonePSY14 NonePSY15 Abbott, Rungis, FrancePSY16 Abbott, Rungis, FrancePSY17 GSK, Marly le Roi, FrancePSY18 NonePSY19 NonePSY20 Baxter International Inc, Deerfield, IL, USAPSY21 NonePSY22 Pfizer Hellas, Athens, GreecePSY23 BERLIN-CHEMIE, Moscow, RussiaPSY24 NonePSY25 Pfizer Brazil, Sao Paulo, BrazilPSY26 Sanofi-Aventis, Prague, Czech RepublicPSY27 Shire HGT, Basingstoke, UKPSY28 Menarini, Barcelona, SpainPSY29 Department of Health UK (Ref. Ref. PHGX09A), London, UKPSY30 Janssen de Mexico, Mexico, MexicoPSY31 Eli Lilly and Company, Indianapolis, IN, USAPSY32 Adelphi Real World, Bollington, UKPSY33 Shire AG, Eysins, SwitzerlandPSY34 Sanofi Pasteur MSD, Maidenhead, UK




PSY35 Forest Research Institute, Jersey City, NJ, USAPSY36 Astellas Pharma A/S, Kastrup, DenmarkPSY37 GlaxoSmithKline, Research Triangle Park, NC, USA; Human Genome

Sciences, Rockville, MD, USAPSY38 Forest Research Institute, Jersey City, NJ, USAPSY39 GlaxoSmithKline, Research Triangle Park, NC, USA; Human Genome

Sciences, Inc., Rockville, MD, USAPSY40 LFB (Laboratoire francais du Fractionnement et des Biotechnologies),

Courtaboeuf, FrancePSY41 Astellas Pharma Global Development, Leiderdorp, NetherlandsPSY42 Abbott Laboratories , Istanbul, TurkeyPSY43 Eli Lilly and Company, Indianapolis, IN, USAPSY44 Genesis Pharma, Athens, TN, GreecePSY45 European Commission (EAHC), Luxembourg, LuxembourgPSY46 Grunenthal GmbH, Aachen, GermanyPSY47 NonePSY48 Janssen, Dublin, Ireland; Roche, Dublin, Ireland; MSD, Dublin, IrelandPSY49 Celgene Corporation, Summit, NJ, USAPUK1 Astellas Pharma, Kastrup, DenmarkPUK2 NonePUK3 NonePUK4 Pfizer Inc., Madrid, SpainPUK5 Baxter Espana, Valencia, SpainPUK6 BMS, Paris, FrancePUK7 NonePUK8 Bristol-Meyers Squibb, Rueil-Malmaison, FrancePUK9 Pfizer Inc., New York, NY, USAPUK10 Astellas Pharma GmbH, Munich, GermanyPUK11 Astellas Pharma s.r.o, Prague, Czech RepublicPUK12 Pfizer Pharma GmbH, Berlin, GermanyPUK13 NonePUK14 Astellas Pharma US, Inc., Northbrook, IL, USA

PUK15 Genzyme, Modena, ItalyPUK16 NonePUK17 GlaxoSmithKline, Moscow, RussiaPUK18 NonePUK19 Pfizer Inc., Madrid, SpainPUK20 GlaxoSmithKline, Marly le Roi, FrancePUK21 Amgen SAS, Neuilly-sur-Seine, FrancePUK22 BMS, Uxbridge, UKPUK23 Abbott GmbH & Co.KG, Wiesbaden, GermanyPUK24 NonePUK25 Allergan, Inc., Irvine, CA, USAQL1 Ministry of Health, Madrid, Spain; EuroQol Group, Rotterdam, NetherlandsQL2 NoneQL3 NoneQL4 University College London, London, UKRE1 Pharmerit International, Rotterdam, NetherlandsRE2 Top Institute Pharma, Leiden, NetherlandsRE3 NoneRE4 NoneRU1 NoneRU2 F. Hoffmann-La Roche Ltd., Basel, SwitzerlandRU3 NoneRU4 Guidelines and Audit Implementation Network, Department of Health, Social

Services and Public Safety Northern Ireland, Belfast, UKUT1 CTMM, Eindhoven, NetherlandsUT2 Janssen-Cilag GmbH, Neuss, GermanyUT3 Hoffman-La Roche, Vancouver, BC, CanadaUT4 Shire Development LLC, Wayne, PA, USAVA1 NoneVA2 NoneVA3 NoneVA4 GlaxoSmithKline Biologicals SA, Rixensart, Belgium




Download - ISPOR 15th Annual European Congress Disclosure Information for Research Presentations

Top Related